Has Sopalla Dul received payments from drug or device companies?

Yes. Drug and device makers reported $2,014 in general payments to Sopalla Dul across 44 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sopalla Dul did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sopalla Dul come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sopalla Dul

Physician Assistant · Burien, WANPI 1205364817

Payments from drug & device makers

$2,014in general payments, 2019–2025

Across 44 payments — averaging $45.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Sanofi$369
Lantheus Medical Imaging, Inc.$279
Inari Medical, Inc.$246
UCB, Inc.$203
Pfizer$190
AbbVie$139
plus $588 from 10 others

What the payments were for

Food & beverage$1,98999%
Education$241%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Sanofi	6	$369
Lantheus Medical Imaging, Inc.	2	$279
Inari Medical, Inc.	1	$246
UCB, Inc.	8	$203
Pfizer	2	$190
AbbVie	2	$139
Johnson & Johnson	7	$139
LEO Pharma Inc.	1	$105
Amgen	4	$94
Sun Pharmaceutical Industries Inc.	2	$80
Biofrontera Inc.	2	$46
Galderma Laboratories, L.p.	1	$35
Lilly USA, LLC	2	$32
Organon	2	$26
Incyte Corporation	1	$16
Paratek Pharmaceuticals, Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,014 in reported general payments places this provider in the 90th percentile of 2,741 physician assistant providers in Washington.

See all physician assistant providers in Washington →

Medicare billing

Part B allowed, 2024

$26,064

Medicare patients

247

Services billed

413

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other physician assistant in Burien

Jill KandoraShoreline$437K
Jeannette HartRichland$263K
Lance KeckTacoma$162K
Erinn KingSeattle$129K
Christy VathSeattle$75K
Scott TaylorMercer Island$71K
Gina FragioneGraham$69K
Regan BrownSpokane$56K
Justin ChapinSeattle$40K
Susan DuffyBellevue$23K

See the full list for Washington →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →